Clinical Study of Benign Lesions in the Oral Cavity

Ono, Yuta; Takahashi, Hiroomi; Inagi, Katsuhide; Nakayama, Meijin; Okamoto, Makito

doi:10.1080/000164802760057644

Cited by 13 publications

(17 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The majority of our patients were in their second, third and fourth decades of life. This differs from findings of others who reported a peak incidence from third to sixth decades [10]. This might reflect the high percentage of young people among the Jordanian population.…”

Section: Discussioncontrasting

confidence: 99%

“…These findings agree with those from other countries [10-12]. Neoplasms constituted 4% of all benign oral soft tissue masses; this is in general agreement with previous series [6, 10, 11]. …”

Section: Discussionsupporting

confidence: 93%

“…The first English-language published review of benign oral soft tissue masses was by Bloodgood [3]. More comprehensive reviews were subsequently published [4-10]. Most of these studies, like the current study, are derived from surgical pathology reports.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Benign Oral Masses in a Northern Jordanian Population-a Retrospective Study

Al-Khateeb¹

2009

TODENTJ

View full text Add to dashboard Cite

The aim of this study was to evaluate the relative frequencies, types and distribution of benign oral masses in North Jordanians. The records of the Department of Pathology at Jordan University of Science & Technology were reviewed and analyzed for patients with benign oral soft tissue masses, received during an 11-year period (1991-2001). The main outcome measures were patients’ age and sex, and the mass type and location. A sum of 818 benign oral soft tissue masses (4% neoplastic and 96% non-neoplastic) was analyzed. Common benign neoplasms were salivary pleomorphic adenoma and lipoma. Non-neoplastic lesions consisted of traumatic (43%) inflammatory/ infective (33%), cystic (14%) and developmental (9%) lesions. Common non-neoplastic lesions were fibroepithelial polyp, pyogenic granuloma, mucoceles, hemangioma and squamous papilloma, in a descending order. There were 330 (40%) males and 488 (60%) females with a male to female ratio of 1: 1.5. The mean age was 33 years, with the majority in the 2nd, 3rd and 4th decades. The sites commonly affected by benign neoplasms were the palate, tongue, upper lip and buccal mucosa, in a descending order and the sites commonly affected by non-neoplastic lesions were the gingiva, buccal mucosa, lower lip and tongue in a descending order. It is concluded that some of the features of benign oral masses in north Jordanians published in this paper are similar to those from other countries, and some are different. Further nationwide population-based surveys are needed to further define the epidemiology of benign oral masses among Jordanians.

show abstract

Section: Discussioncontrasting

confidence: 99%

Section: Discussionsupporting

confidence: 93%

See 1 more Smart Citation

Benign Oral Masses in a Northern Jordanian Population-a Retrospective Study

Al-Khateeb¹

2009

TODENTJ

View full text Add to dashboard Cite

show abstract

“…A stipulation was added for the presence of two or more intraoral fibromas because solitary oral fibromas may occur in the general population, particularly on the tongue or buccal mucosa along the bite line from repeated trauma. 35,36 …”

Section: Clinical Diagnostic Criteriamentioning

confidence: 99%

Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

Northrup

Krueger²

2013

Pediatric Neurology

1,276

1,205

View full text Add to dashboard Cite

BACKGROUND Tuberous sclerosis complex is highly variable in clinical presentation and findings. Disease manifestations continue to develop over the lifetime of an affected individual. Accurate diagnosis is fundamental to implementation of appropriate medical surveillance and treatment. Although significant advances have been made in the past 15 years in the understanding and treatment of tuberous sclerosis complex, current clinical diagnostic criteria have not been critically evaluated or updated since the last clinical consensus conference in 1998. METHODS The 2012 International Tuberous Sclerosis Complex Consensus Group, comprising 79 specialists from 14 countries, was organized into 12 subcommittees, each led by a clinician with advanced expertise in tuberous sclerosis complex and the relevant medical subspecialty. Each subcommittee focused on a specific disease area with important diagnostic implications and was charged with reviewing prevalence and specificity of disease-associated clinical findings and their impact on suspecting and confirming the diagnosis of tuberous sclerosis complex. RESULTS Clinical features of tuberous sclerosis complex continue to be a principal means of diagnosis. Key changes compared with 1998 criteria are the new inclusion of genetic testing results and reducing diagnostic classes from three (possible, probable, and definite) to two (possible, definite). Additional minor changes to specific criterion were made for additional clarification and simplification. CONCLUSIONS The 2012 International Tuberous Sclerosis Complex Diagnostic Criteria provide current, updated means using best available evidence to establish diagnosis of tuberous sclerosis complex in affected individuals.

show abstract

“…They are associated with repeated trauma, and are often termed irritation fibromas. The most common locations are on the tongue and buccal mucosa 16,17 .…”

Section: Discussionmentioning

confidence: 99%